Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Targanta Therapeutics

Request full access

Innovative blockchain solutions for secure patient data storage and advanced crypto trading tools

Cambridge, United StatesFounded 2005Biotech & Life Sciences

About Targanta Therapeutics

Targanta operates at the intersection of healthcare and blockchain technology, providing innovative solutions for the secure storage of patient data. By leveraging blockchain, Targanta ensures data integrity, security, and accessibility, addressing critical needs in the healthcare sector. The company also offers advanced tools for crypto trading, including crypto robots that enhance trading efficiency. Targanta serves healthcare providers, researchers, and traders, operating in the healthcare technology and financial technology markets. The business model revolves around subscription-based services and transaction fees, generating revenue through continuous service provision and trading activities.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
63
Open positions
None listed
Dealroom signal
24.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jan 2009 $42M $42M The Medicines Company —
IPOOther financing Oct 2007 $0 — Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Targanta Therapeutics website traffic

Latest recorded traffic for Targanta Therapeutics is 1.3K monthly website visits, up 97% over the last three months. Targanta Therapeutics's team declined 4.5% over the past year.

Latest monthly visits1.3K 3-month web change+97% 1-year team growth-4.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Targanta Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Targanta Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

Other known investors1 additional known investor

  • The Medicines Company
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Targanta Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Targanta Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.